跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RSV-N
首页
药物
RSV-N
RSV-N
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
申请人: COLLINS PETER L
优先权: 2001
US
2 件公开
NOVEL DOUBLE-STRANDED RNA BASED ON RSV N PROTEIN RNA SEQUENCE, AND USE THEREOF
申请人: TOAGOSEI CO LTD
优先权: 2024
WO
一种抗RSV N蛋白的单克隆抗体及其制备方法和应用
申请人: 龙湖现代免疫实验室
优先权: 2026
CN
Respiratory syncytial virus (RSV) replication inhibitors
申请人: FOND THE ARK
优先权: 2015
US
RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF
申请人: DANA FARBER CANCER INST INC
优先权: 2023
CN
EP
US
WO
4 件公开
Specific monoclonal antibody against the N antigen of human respiratory syncytial virus (hRSV) useful for treating infection, detection thereof and diagnosis
申请人: UNIV PONTIFICIA CATOLICA CHILE
优先权: 2018
EP
US
WO
3 件公开
Respiratory syncytial virus
申请人: YEO ROBERT PAUL
优先权: 2001
US
Inhibitors of RSV replication and applications thereof
申请人: UNIV GEORGIA STATE RES FOUND
优先权: 2018
CN
US
2 件公开
药物
反馈